Skip to content

FDA Approval of 23andMe Genomic Test Shows the Way for Direct-to-Consumer Diagnostics

FDA Approval of 23andMe Genomic Test Shows the Way for Direct-to-Consumer Diagnostics Headshot

Michael L. Fuller

Mike Fuller is a technology enthusiast and widely regarded for his expertise in obtaining, licensing, and managing due diligence on patents involving molecular biology and computer science. Mike is a...